Vaidya Anand, Cui Liufu, Sun Lixia, Lu Bing, Chen Shuohua, Liu Xing, Zhou Yong, Liu Xiurong, Xie Xiaobing, Hu Frank B, Wu Shouling, Gao Xiang
Department of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital & Harvard Medical School, Boston, MA Department of Internal Medicine, Kailuan Hospital Department of Internal Medicine, Hebei Union University Hospital, Tangshan, Hebei Department of Neurology, Beijing Tian Tan Hospital, Capital Medical University, Beijing, China Department of Rheumatology, Brigham and Women's Hospital & Harvard Medical School, Boston, MA Department of respiratory medicine, The People's Hospital of Xinjiang Uygur Autonomous Region, Ürümqi, Xinjiang, China Department of Nutrition, Harvard School of Public Health, Boston, MA Department of Nutritional Science, Penn State University, State College, PA.
Medicine (Baltimore). 2016 Nov;95(46):e5350. doi: 10.1097/MD.0000000000005350.
The worldwide prevalence and incidence of diabetes and obesity are increasing in pandemic proportions. This is particularly relevant for China, where an extremely large population is growing, aging, and urbanizing. We thus conducted a prospective study to examine the prevalence and incidence of impaired fasting glucose (IFG) and diabetes, the rate at which fasting blood glucose rises, and the major modifiable risk factors associated with these outcomes in a large Chinese population from the Kailuan prospective study.A prospective cohort included 100,279 Chinese participants, aged 18 years or more, who had available information on fasting blood glucose concentrations at the start of the study (2006). Examination surveys were conducted every 2 years in 2008 and 2010. For the analyses of incident diabetes, we included 76,869 participants who were free of diabetes, cardiovascular disease, and cancer at the baseline and participants in the 2008 and/or 2010 follow-up. Diabetes was defined by a fasting blood glucose concentration ≥7 mmol/L, self-reported history, or active treatment with insulin or any oral hypoglycemic agent. IFG was defined by a fasting blood glucose concentration between 5.6 and 6.9 mmol/L.During the 4-year study, the prevalence of diabetes and IFG rose from 6.6% to 7.7%, and 17.3% to 22.6%, respectively. There were 17,811 incident cases of IFG and 4867 incident cases of diabetes. The age-standardized incident rate of IFG and diabetes were 62.6/1000 person-years (51.2/1000 person-years in women and 73.8/1000 person-years in men) and 10.0/1000 person-years (7.8/1000 person-years in women and 12.1/1000 person-years in men), respectively. We observed steady increases in fasting blood glucose with body anthropometrics and in every defined category of body mass index, including in those traditionally considered to be well within the "normal" range.In this large longitudinal study of Chinese adults, we observed a high prevalence and incidence of IFG and diabetes over 4 years of follow-up. Our findings are alarming for Chinese public health since steady rises in fasting blood glucose were seen across all permutations of body habitus, even apparently very lean individuals.
糖尿病和肥胖症在全球范围内的患病率和发病率正以大流行的比例上升。这在中国尤为突出,因为其庞大的人口正在经历增长、老龄化和城市化。因此,我们开展了一项前瞻性研究,以调查空腹血糖受损(IFG)和糖尿病的患病率及发病率、空腹血糖上升的速率,以及开滦前瞻性研究中一大群中国人群中与这些结果相关的主要可改变风险因素。一个前瞻性队列包括100279名18岁及以上的中国参与者,他们在研究开始时(2006年)有空腹血糖浓度的相关信息。在2008年和2010年每两年进行一次检查调查。对于新发糖尿病的分析,我们纳入了76869名在基线时无糖尿病、心血管疾病和癌症的参与者以及2008年和/或2010年随访的参与者。糖尿病的定义为空腹血糖浓度≥7 mmol/L、自我报告的病史或正在接受胰岛素或任何口服降糖药治疗。IFG的定义为空腹血糖浓度在5.6至6.9 mmol/L之间。在为期4年的研究中,糖尿病和IFG的患病率分别从6.6%升至7.7%,以及从17.3%升至22.6%。有17811例IFG新发病例和4867例糖尿病新发病例。IFG和糖尿病的年龄标准化发病率分别为62.6/1000人年(女性为51.2/1000人年,男性为73.8/1000人年)和10.0/1000人年(女性为7.8/1000人年,男性为12.1/1000人年)。我们观察到空腹血糖随着身体测量指标以及在每个定义的体重指数类别中稳步上升,包括那些传统上被认为完全处于“正常”范围内的人群。在这项针对中国成年人的大型纵向研究中,我们观察到在4年的随访中IFG和糖尿病的患病率及发病率都很高。我们的研究结果对中国公共卫生而言令人担忧,因为在所有体型组合中空腹血糖都在稳步上升,即使是明显很瘦的个体。